It's not every year that a healthcare company makes Consumer Reports' annual "naughty or nice" list, but this year, CVS Health (NYSE:CVS) made the nice list thanks to its decision to stop selling tobacco-related products in its stores.
CVS Health's decision to eliminate tobacco is controversial to some because it immediately lops $2 billion in annual sales off the company's top line, but the move could end up being a big, long-term win for the pharmacy store chain. In the following video, healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the reasoning behind CVS Health's decision and whether or not they believe investors should consider putting CVS Health on their wish lists.
Todd Campbell is long Rite Aid. Michael Douglass does not own any stocks mentioned, although he thinks pretty hard about CVS from time to time. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned.The Motley Fool recommends CVS Health. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.